In all, we utilized diverse model systems including in vitro cell models, aged and young KPC-based murine models, POD/NOD mouse models, and patient tumor tissues to query cachexia, tumor progression, and 3-MA/Perp mechanisms of action. The gene discussed is PERP; the disease is neoplasm.